Insider Trading History of Turtle Cameron


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Turtle Cameron since year 2005. The trader's CIK number is 1758363. At the time of the last reporting, Turtle Cameron was the Chief Business Officer of Eidos Therapeutics, Inc. . (stock ticker symbol EIDX). See this page for all insider trading activities at Eidos Therapeutics, Inc. .

Note that in the past Turtle Cameron also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Turtle Cameron since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-11-20 EIDX Eidos Therapeutics, Inc. Sale 10,000 55.95 559,510
2019-09-04 EIDX Eidos Therapeutics, Inc. Sale 5,000 41.80 209,000
2019-07-01 BBIO Bridgebio Pharma, Inc. Option Ex 12,630 .00 0
2019-06-04 EIDX Eidos Therapeutics, Inc. Sale 10,000 31.80 318,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Turtle Cameron (Chief Business Officer of Eidos Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month